When standard treatment fails: Jefferson to start unique immunotherapy for brain tumor patients
Wednesday, December 14, 2011 - 16:31
in Health & Medicine
Physicians at the Jefferson Hospital for Neuroscience (JHN), the region's only dedicated hospital, are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with a promising new immunotherapy to attack a patient's tumor with their own cancer cells.